國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

RUNX proteins in development and cancer

Groner, Yoram.

RUNX proteins in development and cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	RUNX proteins in development and canceredited by Yoram Groner ... [et al.].
其他作者:	Groner, Yoram.
出版者:	Singapore :Springer Singapore :2017.
面頁冊數:	xx, 515 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	DNA-binding proteinsCancer
電子資源:	http://dx.doi.org/10.1007/978-981-10-3233-2
ISBN:	9789811032332$q(electronic bk.)

RUNX proteins in development and cancer
RUNX proteins in development and cancer[electronic resource] /edited by Yoram Groner ... [et al.]. - Singapore :Springer Singapore :2017. - xx, 515 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.9620065-2598 ;. - Advances in experimental medicine and biology ;946..

RUNX in invertebrates -- Structure and biophysics of CBFb/RUNX and its transcription products -- Covalent modification of RUNX proteins: structure affects function -- The role of Runx1 in embryonic blood cell formation -- RUNX1 structure and function in blood cell development -- Roles of Runx2 in skeletal development -- Roles of Runx genes in nervous system development -- Runx family genes in tissue stem cell dynamics -- Roles of RUNX1 enhancer in normal hematopoiesis and leukemogenesis -- RUNX1-ETO leukemia -- Clinical relevance of RUNX1 and CBFB alterations in acute myeloid leukemia and other hematological disorders -- Mechanism of ETV6-RUNX1 leukemia -- ETV6-RUNX1+ acute lymphoblastic leukemia in identical twins -- Molecular basis and targeted inhibition of CBFb-SMMHC acute myeloid leukemia -- The RUNX genes as conditional oncogenes: insights from retroviral targeting and mouse models -- RUNX1 and CBFb mutations and activities of their wild-type alleles in AML -- Roles of RUNX in B cell immortalization -- Roles of RUNX in solid tumors -- RUNX3 and p53: How two tumor suppressors cooperate against oncogenic Ras -- Runx3 and cell fate decisions in pancreas cancer -- RUNX genes in breast cancer and the mammary lineage -- Runx3 in immunity, inflammation and cancer -- Roles of RUNX complexes in immune cell development -- CBFb and HIV infection -- Roles of RUNX in Hippo pathway signaling -- Roles of RUNX in hypoxia-induced responses and angiogenesis -- The emerging roles of RUNX transcription factors in Epithelial-Mesenchymal Transition -- Regulatory role of RUNX1 and RUNX3 in the maintenance of genomic integrity.

This volume provides the reader with an overview of the diverse functions of the RUNX family of genes. As highlighted in the introduction and several of the 29 chapters, humans and other mammals have three RUNX genes that are known to play specific roles in blood, bone and neuronal development. However, their evolutionary history has recently been traced back to unicellular organisms and their involvement in many well-known signaling pathways (Wnt, TGFb, Notch, Hippo) is indicative of a more general function in cell biology. Their documented roles in cell fate decisions include control of proliferation, differentiation, survival, senescence and autophagy. The pleiotropic effects of RUNX in development are mirrored in cancer, where RUNX genes can function as oncogenes that collaborate strongly with Myc family oncogenes or as tumour suppressor genes. In the latter role, they display hallmarks of both 'gatekeepers' that modulate p53 responses and 'caretakers' that protect the genome from DNA damage. Several chapters focus on the importance of these genes in leukemia research, where RUNX1 and CBFB are frequently affected by chromosomal translocations that generate fusion oncoproteins, while recent studies suggest wider roles for RUNX modulation in solid cancers. Moreover, RUNX genes are intimately involved in the development and regulation of the immune system, while emerging evidence suggests a role in innate immunity to infectious agents, including HIV. At the biochemical level, the RUNX family can serve as activators or repressors of transcription and as stable mediators of epigenetic memory through mitosis. Not surprisingly, RUNX activity is controlled at multiple levels, this includes miRNAs and a plethora of post-translational modifications. Several chapters highlight the interplay between the three mammalian RUNX genes, where cross-talk and partial functional redundancies are evident. Finally, structural analysis of the RUNX/CBFB interaction has led to the development of small molecule inhibitors that provide exciting new tools to decipher the roles of RUNX in development and as targets for therapy. This volume provides a compendium and reference source that will be of broad interest to cancer researchers, developmental biologists and immunologists.

ISBN: 9789811032332$q(electronic bk.)

Standard No.: 10.1007/978-981-10-3233-2doiSubjects--Topical Terms:

775210
DNA-binding proteins
--Cancer

LC Class. No.: QP624.75.P74

Dewey Class. No.: 572.86

RUNX proteins in development and cancer
LDR:05000nmm a2200337 a 4500 001 508806
003 DE-He213
005 20170315105341.0
006 m d
007 cr nn 008maaau
008 171121s2017 si s 0 eng d
020 $a 9789811032332$q(electronic bk.)
020 $a 9789811032318$q(paper)
024 7 $a 10.1007/978-981-10-3233-2 $2 doi
035 $a 978-981-10-3233-2
040 $a GP $c GP
041 0 $a eng
050 4 $a QP624.75.P74
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
072 7 $a SCI029000 $2 bisacsh
082 0 4 $a 572.86 $2 23
090 $a QP624.75.P74 $b R943 2017
245 0 0 $a RUNX proteins in development and cancer $h [electronic resource] / $c edited by Yoram Groner ... [et al.].
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a xx, 515 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.962
505 0 $a RUNX in invertebrates -- Structure and biophysics of CBFb/RUNX and its transcription products -- Covalent modification of RUNX proteins: structure affects function -- The role of Runx1 in embryonic blood cell formation -- RUNX1 structure and function in blood cell development -- Roles of Runx2 in skeletal development -- Roles of Runx genes in nervous system development -- Runx family genes in tissue stem cell dynamics -- Roles of RUNX1 enhancer in normal hematopoiesis and leukemogenesis -- RUNX1-ETO leukemia -- Clinical relevance of RUNX1 and CBFB alterations in acute myeloid leukemia and other hematological disorders -- Mechanism of ETV6-RUNX1 leukemia -- ETV6-RUNX1+ acute lymphoblastic leukemia in identical twins -- Molecular basis and targeted inhibition of CBFb-SMMHC acute myeloid leukemia -- The RUNX genes as conditional oncogenes: insights from retroviral targeting and mouse models -- RUNX1 and CBFb mutations and activities of their wild-type alleles in AML -- Roles of RUNX in B cell immortalization -- Roles of RUNX in solid tumors -- RUNX3 and p53: How two tumor suppressors cooperate against oncogenic Ras -- Runx3 and cell fate decisions in pancreas cancer -- RUNX genes in breast cancer and the mammary lineage -- Runx3 in immunity, inflammation and cancer -- Roles of RUNX complexes in immune cell development -- CBFb and HIV infection -- Roles of RUNX in Hippo pathway signaling -- Roles of RUNX in hypoxia-induced responses and angiogenesis -- The emerging roles of RUNX transcription factors in Epithelial-Mesenchymal Transition -- Regulatory role of RUNX1 and RUNX3 in the maintenance of genomic integrity.
520 $a This volume provides the reader with an overview of the diverse functions of the RUNX family of genes. As highlighted in the introduction and several of the 29 chapters, humans and other mammals have three RUNX genes that are known to play specific roles in blood, bone and neuronal development. However, their evolutionary history has recently been traced back to unicellular organisms and their involvement in many well-known signaling pathways (Wnt, TGFb, Notch, Hippo) is indicative of a more general function in cell biology. Their documented roles in cell fate decisions include control of proliferation, differentiation, survival, senescence and autophagy. The pleiotropic effects of RUNX in development are mirrored in cancer, where RUNX genes can function as oncogenes that collaborate strongly with Myc family oncogenes or as tumour suppressor genes. In the latter role, they display hallmarks of both 'gatekeepers' that modulate p53 responses and 'caretakers' that protect the genome from DNA damage. Several chapters focus on the importance of these genes in leukemia research, where RUNX1 and CBFB are frequently affected by chromosomal translocations that generate fusion oncoproteins, while recent studies suggest wider roles for RUNX modulation in solid cancers. Moreover, RUNX genes are intimately involved in the development and regulation of the immune system, while emerging evidence suggests a role in innate immunity to infectious agents, including HIV. At the biochemical level, the RUNX family can serve as activators or repressors of transcription and as stable mediators of epigenetic memory through mitosis. Not surprisingly, RUNX activity is controlled at multiple levels, this includes miRNAs and a plethora of post-translational modifications. Several chapters highlight the interplay between the three mammalian RUNX genes, where cross-talk and partial functional redundancies are evident. Finally, structural analysis of the RUNX/CBFB interaction has led to the development of small molecule inhibitors that provide exciting new tools to decipher the roles of RUNX in development and as targets for therapy. This volume provides a compendium and reference source that will be of broad interest to cancer researchers, developmental biologists and immunologists.
650 0 $a DNA-binding proteins $x Cancer $x Research. $3 775210
650 0 $a Life sciences. $3 215795
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Gene Function. $3 456568
650 2 4 $a Oncology. $3 195181
650 2 4 $a Protein Science. $3 376428
700 1 $a Groner, Yoram. $3 775209
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-3233-2
950 $a Biomedical and Life Sciences (Springer-11642)